Exact Mass: 285.2308

Exact Mass Matches: 285.2308

Found 164 metabolites which its exact mass value is equals to given mass value 285.2308, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Mepyramine

N-[(4-Methoxyphenyl)methyl]-n,n-dimethyl-N-2-pyridinyl-1,2-ethanediamine

C17H23N3O (285.1841)


Mepyramine (also known as pyrilamine) is a first generation antihistamine, targeting the H1 receptor. However, it rapidly permeates the brain and so often causes drowsiness as a side effect. It is used in over-the-counter combination products for colds and menstrual symptoms. D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist CONFIDENCE standard compound; EAWAG_UCHEM_ID 3006 D018926 - Anti-Allergic Agents

   

Pentazocine

(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6-trien-4-ol

C19H27NO (285.2093)


Pentazocine is only found in individuals that have used or taken this drug. It is the first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)The preponderance of evidence suggests that pentazocine antagonizes the opioid effects by competing for the same receptor sites, especially the opioid mu receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics

   

1-Methyl-2-nonyl-4(1H)-quinolinone

1-Methyl-2-nonyl-4(1H)-quinolinone; 1-Methyl-2-n-nonyl-4(1H) quinolone; 1-Methyl-2-nonyl-4(1H)-quinolone

C19H27NO (285.2093)


1-Methyl-2-nonyl-4(1H)-quinolinone is a member of quinolines. 1-Methyl-2-nonylquinolin-4(1H)-one is a natural product found in Raulinoa echinata, Tetradium ruticarpum, and other organisms with data available. 1-Methyl-2-nonyl-4(1H)-quinolinone is found in herbs and spices. 1-Methyl-2-nonyl-4(1H)-quinolinone is an alkaloid from Ruta graveolens (rue

   

Myristoylglycine

N-Myristoylglycine, potassium salt

C16H31NO3 (285.2304)


Myristoylglycine is an acylglycine with C-14 fatty acid group as the acyl moiety. Acylglycines 1 possess a common amidoacetic acid moiety and are normally minor metabolites of fatty acids. Elevated levels of certain acylglycines appear in the urine and blood of patients with various fatty acid oxidation disorders. They are normally produced through the action of glycine N-acyltransferase which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine ↔ CoA + N-acylglycine. Myristoylglycine is an acylglycine with C-14 fatty acid group as the acyl moiety.

   

2-Octenoylcarnitine

(3S)-3-[(2E)-Oct-2-enoyloxy]-4-(trimethylammonio)butanoic acid

C15H27NO4 (285.194)


2-Octenoylcarnitine is an acylcarnitine. More specifically, it is an 2-octenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octenoyl-L-carnitine

3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]undec-5-enoate

C15H27NO4 (285.194)


Octenoyl-L-carnitine is an acylcarnitine. More specifically, it is an octenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Octenoyl-L-carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Octenoyl-L-carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Octenoylcarnitine

3-[(2E)-Oct-2-enoyloxy]-4-(trimethylammonio)butanoic acid

C15H27NO4 (285.194)


(2E)-Octenoylcarnitine is an acylcarnitine. More specifically, it is an (2E)-Octenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Octenoylcarnitine

3-(oct-3-enoyloxy)-4-(trimethylazaniumyl)butanoate

C15H27NO4 (285.194)


3-Octenoylcarnitine is an acylcarnitine. More specifically, it is an oct-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Octenoylcarnitine

3-(oct-6-enoyloxy)-4-(trimethylazaniumyl)butanoate

C15H27NO4 (285.194)


6-Octenoylcarnitine is an acylcarnitine. More specifically, it is an oct-6-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Octenoylcarnitine

3-(oct-4-enoyloxy)-4-(trimethylazaniumyl)butanoate

C15H27NO4 (285.194)


4-Octenoylcarnitine is an acylcarnitine. More specifically, it is an oct-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Octenoylcarnitine

3-(oct-5-enoyloxy)-4-(trimethylazaniumyl)butanoate

C15H27NO4 (285.194)


5-Octenoylcarnitine is an acylcarnitine. More specifically, it is an oct-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Octenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Octenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Propylpent-4-enoylcarnitine

3-[(2-propylpent-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO4 (285.194)


2-Propylpent-4-enoylcarnitine is an acylcarnitine. More specifically, it is an 2-propylpent-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Propylpent-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Propylpent-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-2-Propylpent-2-enoylcarnitine

3-[(2-propylpent-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO4 (285.194)


(2E)-2-Propylpent-2-enoylcarnitine is an acylcarnitine. More specifically, it is an (2E)-2-propylpent-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-2-Propylpent-2-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-2-Propylpent-2-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(3Z)-2-Propylpent-3-enoylcarnitine

3-[(2-Propylpent-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H27NO4 (285.194)


(3Z)-2-Propylpent-3-enoylcarnitine is an acylcarnitine. More specifically, it is an (3Z)-2-propylpent-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3Z)-2-Propylpent-3-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3Z)-2-Propylpent-3-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(+)-Pentazocine

1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5-trien-4-ol

C19H27NO (285.2093)


   

Dehydroabietylamine

[1,4a-dimethyl-7-(propan-2-yl)-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl]methanamine

C20H31N (285.2456)


   

Pirotiodecane

1-[2-(Decylsulphanyl)ethyl]pyrrolidin-2-one

C16H31NOS (285.2126)


   

5-(4-Methylphenyl)-7-tert-butyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-d]pyrimidine-4-amine

5-(4-Methylphenyl)-7-tert-butyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-d]pyrimidine-4-amine

C16H23N5 (285.1953)


   

Trachelanthamine

[(1R,8S)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1R)-1-hydroxyethyl]-3-methylbutanoate

C15H27NO4 (285.194)


Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Pyrrolizidine alkaloids (2S,3R)-((1R,7aS)-hexahydro-1H-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-isopropylbutanoate is a natural product found in Eupatorium cannabinum, Trachelanthus korolkowii, and other organisms with data available.

   

14-methyl-2-pentadecenethioamide S-oxide

14-methyl-2-pentadecenethioamide S-oxide

C16H31NOS (285.2126)


   

Dihydroabietylamine

Dihydroabietylamine

C20H31N (285.2456)


   

N-(2-Hydroxyethyl)pentadecanamide

N-(2-Hydroxyethyl)pentadecanamide

C17H35NO2 (285.2668)


   

(-)-histrionicotoxin 285C|(?)-histrionicotoxin 285C|allodihydrohistrionicotoxin

(-)-histrionicotoxin 285C|(?)-histrionicotoxin 285C|allodihydrohistrionicotoxin

C19H27NO (285.2093)


   

2-Decyl-1H-quinolin-4-one

2-Decyl-1H-quinolin-4-one

C19H27NO (285.2093)


   

(2S,3R,E)-2-Amino-4-heptadecene-1,3-diol

(2S,3R,E)-2-Amino-4-heptadecene-1,3-diol

C17H35NO2 (285.2668)


   

3-Methyl-2-nonyl-1H-quinolin-4-one

3-Methyl-2-nonyl-1H-quinolin-4-one

C19H27NO (285.2093)


   

Lindelofine

Lindelofine

C15H27NO4 (285.194)


   

2,4,10-Tetradecatrien-8-ynoic acid piperidide

2,4,10-Tetradecatrien-8-ynoic acid piperidide

C19H27NO (285.2093)


   

(2R,3S)-2-acetamido-3-acetoxydodecane|clavaminol I

(2R,3S)-2-acetamido-3-acetoxydodecane|clavaminol I

C16H31NO3 (285.2304)


   

(2E,9Z)-N-isobutylpentadeca-2,9-diene-12,14-diynamide|2,9-Pentadecadiene-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-dien-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-diene-12,14-diynoic acid isobutylamide|pentadeca-2t,9c-dien-12,14-diynoic acid isobutylamide

(2E,9Z)-N-isobutylpentadeca-2,9-diene-12,14-diynamide|2,9-Pentadecadiene-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-dien-12,14-diynoic acid isobutylamide|pentadeca-2E,9Z-diene-12,14-diynoic acid isobutylamide|pentadeca-2t,9c-dien-12,14-diynoic acid isobutylamide

C19H27NO (285.2093)


   

PSN375963

4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridine

C17H23N3O (285.1841)


   

pyrilamine

PYR_286.1915_11.5

C17H23N3O (285.1841)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents CONFIDENCE Parent Substance with Reference Standard (Level 1); INTERNAL_ID 1700

   

dehydroabietylamine

(+)-Dehydroabiethylamine

C20H31N (285.2456)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.139 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.136

   

1-methyl-2-nonylquinolin-4-one

NCGC00385599-01!1-methyl-2-nonylquinolin-4-one

C19H27NO (285.2093)


   

Pentazocine

(R)-Pentazocine

C19H27NO (285.2093)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AD - Benzomorphan derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Pentadecanoyl Ethanolamide

N-(2-Hydroxyethyl)pentadecanamide

C17H35NO2 (285.2668)


CONFIDENCE standard compound; INTERNAL_ID 29 INTERNAL_ID 29; CONFIDENCE standard compound

   

Viridiflorine

Viridiflorine

C15H27NO4 (285.194)


Annotation level-1

   

1-methyl-2-nonylquinolin-4-one [IIN-based on: CCMSLIB00000845108]

NCGC00385599-01!1-methyl-2-nonylquinolin-4-one [IIN-based on: CCMSLIB00000845108]

C19H27NO (285.2093)


   

1-methyl-2-nonylquinolin-4-one [IIN-based: Match]

NCGC00385599-01!1-methyl-2-nonylquinolin-4-one [IIN-based: Match]

C19H27NO (285.2093)


   

Sphingosine (C17 base)

Sphingosine (C17 base)

C17H35NO2 (285.2668)


   

trans-2-Octenoyl-carnitine; AIF; CE0; CorrDec

trans-2-Octenoyl-carnitine; AIF; CE0; CorrDec

C15H27NO4 (285.194)


   

trans-2-Octenoyl-carnitine; AIF; CE10; CorrDec

trans-2-Octenoyl-carnitine; AIF; CE10; CorrDec

C15H27NO4 (285.194)


   

trans-2-Octenoyl-carnitine; AIF; CE30; CorrDec

trans-2-Octenoyl-carnitine; AIF; CE30; CorrDec

C15H27NO4 (285.194)


   

trans-2-Octenoyl-carnitine; AIF; CE0; MS2Dec

trans-2-Octenoyl-carnitine; AIF; CE0; MS2Dec

C15H27NO4 (285.194)


   

trans-2-Octenoyl-carnitine; AIF; CE10; MS2Dec

trans-2-Octenoyl-carnitine; AIF; CE10; MS2Dec

C15H27NO4 (285.194)


   

trans-2-Octenoyl-carnitine; AIF; CE30; MS2Dec

trans-2-Octenoyl-carnitine; AIF; CE30; MS2Dec

C15H27NO4 (285.194)


   

Octenoyl-carnitine; LC-tDDA; CE10

Octenoyl-carnitine; LC-tDDA; CE10

C15H27NO4 (285.194)


   

Octenoyl-carnitine; LC-tDDA; CE20

Octenoyl-carnitine; LC-tDDA; CE20

C15H27NO4 (285.194)


   

Octenoyl-carnitine; LC-tDDA; CE30

Octenoyl-carnitine; LC-tDDA; CE30

C15H27NO4 (285.194)


   

Octenoyl-carnitine; LC-tDDA; CE40

Octenoyl-carnitine; LC-tDDA; CE40

C15H27NO4 (285.194)


   

6-decanamidohexanoic acid

6-decanamidohexanoic acid

C16H31NO3 (285.2304)


   

C17_Sphingosine

C17_Sphingosine

C17H35NO2 (285.2668)


Sphingosine (d17:1) is a 17-carbon sphingosine found in human skin. Sphingosine (d17:1) can be phosphorylated by sphingosine kinases to produce C-17 sphingosine-1-phosphate. Sphingosine C-17 was used as an internal standard for spectral analysis of sphingoid compounds[1][2][3].

   

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-buta-1,3-dien-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2R,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(pent-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2R,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-(pent-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-penta-2,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

C17 Sphingosine

2S-amino-4E-heptadecene-1,3R-diol

C17H35NO2 (285.2668)


Sphingosine (d17:1) is a 17-carbon sphingosine found in human skin. Sphingosine (d17:1) can be phosphorylated by sphingosine kinases to produce C-17 sphingosine-1-phosphate. Sphingosine C-17 was used as an internal standard for spectral analysis of sphingoid compounds[1][2][3].

   

18-AMINOABIETA-8,11,13-TRIENE

18-AMINOABIETA-8,11,13-TRIENE

C20H31N (285.2456)


   

Leelamine (hydrochloride)

1R,2,3,4,4aS,9,10,10aR-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenemethanamine, monohydrochloride

C20H31N (285.2456)


   

Pentadecanoyl-EA

N-(Pentadecanoyl)-ethanolamine

C17H35NO2 (285.2668)


   

15-methyl-hexadecasphingosine

iso (4E,15-methyl-d16:1) sphingosine

C17H35NO2 (285.2668)


   

14-methyl-hexadecasphingosine

anteiso (4E,14-methyl-d16:1) sphingosine

C17H35NO2 (285.2668)


   

1-methyl-2-nonyl-4(1h)-quinolinone

1-methyl-2-nonyl-1,4-dihydroquinolin-4-one

C19H27NO (285.2093)


   

CAR 8:1

(3S)-3-[(2E)-oct-2-enoyloxy]-4-(trimethylammonio)butanoate;(E)-2-octenoyl-L-carnitine;2-octenoylcarnitine

C15H27NO4 (285.194)


   

NAE 15:0

N-(Pentadecanoyl)-ethanolamine

C17H35NO2 (285.2668)


   

SPB 17:1;O2

anteiso (4E,14-methyl-d16:1) sphingosine

C17H35NO2 (285.2668)


   

((1S,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHREN-1-YL)METHANAMINE

((1S,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHREN-1-YL)METHANAMINE

C20H31N (285.2456)


   

TERT-BUTYL 2-((TERT-BUTOXYCARBONYL)AMINO)HEX-5-ENOATE

TERT-BUTYL 2-((TERT-BUTOXYCARBONYL)AMINO)HEX-5-ENOATE

C15H27NO4 (285.194)


   

b-Alanine, N-tetradecyl-

b-Alanine, N-tetradecyl-

C17H35NO2 (285.2668)


   

1-BOC-2-[(2-DIMETHYLAMINO-ETHYLAMINO)-METHYL]-PIPERIDINE

1-BOC-2-[(2-DIMETHYLAMINO-ETHYLAMINO)-METHYL]-PIPERIDINE

C15H31N3O2 (285.2416)


   

1-BOC-3-(2-MORPHOLIN-4-YL-ETHYLAMINO)-AZETIDINE

1-BOC-3-(2-MORPHOLIN-4-YL-ETHYLAMINO)-AZETIDINE

C14H27N3O3 (285.2052)


   

tert-butyl 4-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate

tert-butyl 4-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate

C15H27NO4 (285.194)


   

Ethyl [trans-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)cyclohe xyl]acetate

Ethyl [trans-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)cyclohe xyl]acetate

C15H27NO4 (285.194)


   

3-Methyl 1-(2-methyl-2-propanyl) 3-isopropyl-1,3-piperidinedicarb oxylate

3-Methyl 1-(2-methyl-2-propanyl) 3-isopropyl-1,3-piperidinedicarb oxylate

C15H27NO4 (285.194)


   
   

PHENOL, 2-(1,1-DIMETHYLETHYL)-6-(1-METHYLETHYL)-4-(3-PYRIDAZINYLAMINO)-

PHENOL, 2-(1,1-DIMETHYLETHYL)-6-(1-METHYLETHYL)-4-(3-PYRIDAZINYLAMINO)-

C17H23N3O (285.1841)


   

Ethyl 1-Boc-3-ethylpiperidine-3-carboxylate

Ethyl 1-Boc-3-ethylpiperidine-3-carboxylate

C15H27NO4 (285.194)


   

1-Decyl-3-methylimidazolium nitrate

1-Decyl-3-methylimidazolium nitrate

C14H27N3O3 (285.2052)


   

1-Benzyl-4-morpholinopiperidine-4-carbonitrile

1-Benzyl-4-morpholinopiperidine-4-carbonitrile

C17H23N3O (285.1841)


   

Ethyl 1-Boc-4-ethyl-4-piperidine carboxylate

Ethyl 1-Boc-4-ethyl-4-piperidine carboxylate

C15H27NO4 (285.194)


   

N-Methyl-N-(2-(4-aminophenoxy)ethyl)-2-(4-aminophenyl)ethanamine

N-Methyl-N-(2-(4-aminophenoxy)ethyl)-2-(4-aminophenyl)ethanamine

C17H23N3O (285.1841)


   
   

KDM2/7-IN-1

KDM2/7-IN-1

C15H27NO4 (285.194)


   

tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate

tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate

C14H27N3O3 (285.2052)


   

(S)-TERT-BUTYL 3-(TERT-BUTYLCARBAMOYL)PIPERAZINE-1-CARBOXYLATE

(S)-TERT-BUTYL 3-(TERT-BUTYLCARBAMOYL)PIPERAZINE-1-CARBOXYLATE

C14H27N3O3 (285.2052)


   

(R)-4-BOC-PIPERAZINE-2-CARBOXYL-T-BUTYLAMIDE

(R)-4-BOC-PIPERAZINE-2-CARBOXYL-T-BUTYLAMIDE

C14H27N3O3 (285.2052)


   

Pirotiodecane

Pirotiodecane

C16H31NOS (285.2126)


   

Dodecyl 2-(dimethylamino)propanoate

Dodecyl 2-(dimethylamino)propanoate

C17H35NO2 (285.2668)


   

2-Octenoyl carnitine

2-Octenoyl carnitine

C15H27NO4 (285.194)


   

(1R,7aS)-hexahydro-1H-pyrrolizin-1-ylmethyl 2,3-dihydroxy-2-(propan-2-yl)butanoate

(1R,7aS)-hexahydro-1H-pyrrolizin-1-ylmethyl 2,3-dihydroxy-2-(propan-2-yl)butanoate

C15H27NO4 (285.194)


   

6-(Decanoylamino)hexanoic acid

6-(Decanoylamino)hexanoic acid

C16H31NO3 (285.2304)


   

5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid

5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid

C16H31NO3 (285.2304)


   

(hexahydro-1H-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-(propan-2-yl)butanoate

(hexahydro-1H-pyrrolizin-1-yl)methyl 2,3-dihydroxy-2-(propan-2-yl)butanoate

C15H27NO4 (285.194)


   

omega-Hydroxy-15-methylpalmitate

omega-Hydroxy-15-methylpalmitate

C17H33O3- (285.243)


A hydroxy fatty acid anion that is the conjugate base of omega-hydroxy-15-methyl-palmitic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

2-Propylpent-4-enoylcarnitine

2-Propylpent-4-enoylcarnitine

C15H27NO4 (285.194)


   

3-Octenoylcarnitine

3-Octenoylcarnitine

C15H27NO4 (285.194)


   

(2e)-Octenoyl-carnitine

(2e)-Octenoyl-carnitine

C15H27NO4 (285.194)


   

6-Octenoylcarnitine

6-Octenoylcarnitine

C15H27NO4 (285.194)


   

4-Octenoylcarnitine

4-Octenoylcarnitine

C15H27NO4 (285.194)


   

5-Octenoylcarnitine

5-Octenoylcarnitine

C15H27NO4 (285.194)


   

(2E)-2-Propylpent-2-enoylcarnitine

(2E)-2-Propylpent-2-enoylcarnitine

C15H27NO4 (285.194)


   

(3Z)-2-Propylpent-3-enoylcarnitine

(3Z)-2-Propylpent-3-enoylcarnitine

C15H27NO4 (285.194)


   

Leelamine

Leelamine

C20H31N (285.2456)


   

Acylcarnitine C8:1

Acylcarnitine C8:1

C15H27NO4 (285.194)


   

4-Heptadecene-1,3-diol, 2-amino-, (2S,3R,4E)-

4-Heptadecene-1,3-diol, 2-amino-, (2S,3R,4E)-

C17H35NO2 (285.2668)


   

3-Dehydro-15-methylhexadecasphinganine

3-Dehydro-15-methylhexadecasphinganine

C17H35NO2 (285.2668)


   

11-Oxomiltiradiene(1-)

11-Oxomiltiradiene(1-)

C20H29O- (285.2218)


An organic anion that is the conjugate base of 11-oxomiltiradiene, arising from the deprotonation of the methylene group at position 14. Major species at pH 7.3.

   

(Z)-cyclopropyl-methoxymycolate

(Z)-cyclopropyl-methoxymycolate

C16H29O4- (285.2066)


   

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]acetamide

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]acetamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]heptanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]heptanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]pentanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]propanamide

C16H31NO3 (285.2304)


   

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]butanamide

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]butanamide

C16H31NO3 (285.2304)


   

1-Octyl-2,2,6,6-tetramethyl-2,6-disilapiperidine

1-Octyl-2,2,6,6-tetramethyl-2,6-disilapiperidine

C15H35NSi2 (285.2308)


   

Talwin

Talwin

C19H27NO (285.2093)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics

   

2-Octenoylcarnitine

2-Octenoylcarnitine

C15H27NO4 (285.194)


   

N-Myristoylglycine

N-Myristoylglycine

C16H31NO3 (285.2304)


An N-acylglycine in which the acyl group is specified as myristoyl (tetradecanoyl).

   

(2E)-octenoylcarnitine

(2E)-octenoylcarnitine

C15H27NO4 (285.194)


An O-acylcarnitine having (2E)-octenoyl as the acyl substituent.

   

O-octenoylcarnitine

O-octenoylcarnitine

C15H27NO4 (285.194)


An O-acylcarnitine in which the acyl group specified is octenoyl.

   

Octenoyl-L-carnitine

Octenoyl-L-carnitine

C15H27NO4 (285.194)


An O-acyl-L-carnitine that is L-carnitine having a octenoyl group as the acyl substituent in which the position of the double bond is unspecified.

   

2-octenoyl-L-carnitine

2-octenoyl-L-carnitine

C15H27NO4 (285.194)


An octenoyl-Lcarnitine having 2-octenoyl as the acyl substituent.

   

Sphingosine (d17:1)

SPH(d17:1)

C17H35NO2 (285.2668)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   

Cer 14:1;O2/2:0

Cer 14:1;O2/2:0

C16H31NO3 (285.2304)


   
   

Cer 8:1;O2/8:0

Cer 8:1;O2/8:0

C16H31NO3 (285.2304)


   

(1r,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

(1r,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

C15H27NO4 (285.194)


   

n-[(2r,3s)-3-(acetyloxy)dodecan-2-yl]ethanimidic acid

n-[(2r,3s)-3-(acetyloxy)dodecan-2-yl]ethanimidic acid

C16H31NO3 (285.2304)


   

(2e,4e,10z)-1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one

(2e,4e,10z)-1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one

C19H27NO (285.2093)


   

n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid

n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid

C19H27NO (285.2093)


   

(2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methyl-butyric acid [(1R,8R)-pyrrolizidin-1-yl]methyl ester

(2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methylbutanoic acid [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl ester; [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methyl-butanoate; 487-99-0; [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methylbutanoate; Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (hexahydro-1H-pyrrolizin-1-yl)methyl ester, (1R-(1alpha(2S*,3R*),7abeta))-

C15H27NO4 (285.194)


{"Ingredient_id": "HBIN006594","Ingredient_name": "(2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methyl-butyric acid [(1R,8R)-pyrrolizidin-1-yl]methyl ester","Alias": "(2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methylbutanoic acid [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl ester; [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methyl-butanoate; 487-99-0; [(1R,8R)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-(1-hydroxyethyl)-3-methylbutanoate; Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (hexahydro-1H-pyrrolizin-1-yl)methyl ester, (1R-(1alpha(2S*,3R*),7abeta))-","Ingredient_formula": "C15H27NO4","Ingredient_Smile": "CC(C)C(C(C)O)(C(=O)OCC1CCN2C1CCC2)O","Ingredient_weight": "285.38","OB_score": "18.84516742","CAS_id": "487-99-0","SymMap_id": "SMIT03157","TCMID_id": "NA","TCMSP_id": "MOL000599","TCM_ID_id": "NA","PubChem_id": "164622","DrugBank_id": "NA"}

   

(2e,9z)-n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid

(2e,9z)-n-(2-methylpropyl)pentadeca-2,9-dien-12,14-diynimidic acid

C19H27NO (285.2093)


   

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H27NO4 (285.194)


   

(2s,6r,7s,8r)-7-[(1e)-buta-1,3-dien-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8r)-7-[(1e)-buta-1,3-dien-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(2s,3s)-n-[(1s)-1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid

(2s,3s)-n-[(1s)-1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid

C14H27N3O3 (285.2052)


   

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

n-[1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid

n-[1-(c-hydroxycarbonimidoyl)-3-methylbutyl]-2-[(1-hydroxyethylidene)amino]-3-methylpentanimidic acid

C14H27N3O3 (285.2052)


   

n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide

n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide

C19H27NO (285.2093)


   

(4e,7e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

(4e,7e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

C16H28ClNO (285.1859)


   

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2,3-dihydroxy-2-isopropylbutanoate

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2,3-dihydroxy-2-isopropylbutanoate

C15H27NO4 (285.194)


   

7-(but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

7-(but-1-en-3-yn-1-yl)-2-(penta-3,4-dien-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H27NO4 (285.194)


   

7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

C16H28ClNO (285.1859)


   

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

(1s,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

C15H27NO4 (285.194)


   

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

C15H27NO4 (285.194)


   

1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one

1-(piperidin-1-yl)tetradeca-2,4,10-trien-8-yn-1-one

C19H27NO (285.2093)


   

(1r,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

(1r,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H27NO4 (285.194)


   

(2e,4e)-n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide

(2e,4e)-n-methyl-n-(2-methylpropyl)tetradeca-2,4-dien-8,10-diynamide

C19H27NO (285.2093)


   

coromandaline

coromandaline

C15H27NO4 (285.194)


   

n-[3-(acetyloxy)dodecan-2-yl]ethanimidic acid

n-[3-(acetyloxy)dodecan-2-yl]ethanimidic acid

C16H31NO3 (285.2304)


   

(2s,6r,7s,8r)-7-(buta-1,3-dien-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8r)-7-(buta-1,3-dien-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H27NO (285.2093)


   

(4e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

(4e)-7-(chloromethylidene)-n-(3-methylbutyl)dec-4-enimidic acid

C16H28ClNO (285.1859)


   

(2e,4e)-n-(3-methylbutyl)tetradeca-2,4-dien-8,10-diynimidic acid

(2e,4e)-n-(3-methylbutyl)tetradeca-2,4-dien-8,10-diynimidic acid

C19H27NO (285.2093)


   

(2e)-14-methyl-1-sulfinylidenepentadec-2-en-1-amine

(2e)-14-methyl-1-sulfinylidenepentadec-2-en-1-amine

C16H31NOS (285.2126)